Product image of Xalkori (Crizotinib) supplied by GNH India

Xalkori

Active Ingredient:
Crizotinib
Origin:
EU

Xalkori (Crizotinib)

Xalkori (Crizotinib) is an oral prescription medicine used for treating certain types of non-small cell lung cancer. This targeted therapy works by blocking specific proteins that promote cancer cell growth. Always consult a healthcare professional before use.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xalkori (Crizotinib) is prescribed to treat adults with non-small cell lung cancer that is anaplastic lymphoma kinase (ALK)-positive or ROS1-positive. It is also used for metastatic non-small cell lung cancer with MET exon 14 skipping alterations. Patients often ask, 'what is Crizotinib used for' in targeted cancer therapy. This medication helps control disease progression in these specific cancer types.

Side Effects

  • Common effects of Xalkori (Crizotinib) may include nausea, vomiting, diarrhea, or fatigue. Some users report vision changes, such as flashes of light or blurred vision. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

  • Store Xalkori (Crizotinib) at room temperature away from moisture and heat. Keep this medication in its original packaging until ready to use. Always handle with care and follow local disposal guidelines for unused or expired medicines. Do not crush, split, or chew capsules.

Avoid Interactions

  • Xalkori (Crizotinib) may interact with strong CYP3A inhibitors or inducers, altering its effectiveness. Grapefruit products and certain herbal supplements can also affect how this medication works. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Xalkori (Crizotinib) is used to treat specific types of non-small cell lung cancer, including ALK-positive, ROS1-positive, and MET exon 14 skipping alterations.

Xalkori (Crizotinib) is taken orally as capsules, usually twice daily with or without food. Follow your doctor's prescribed dosing instructions exactly.

Common side effects may include nausea, vomiting, diarrhea, fatigue, or vision changes. Report any persistent effects to your healthcare provider.

Xalkori (Crizotinib) may interact with many medications, including strong CYP3A inhibitors or inducers. Always consult your doctor before combining treatments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Crizotinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT